Biotech

All Articles

Boundless Bio helps make 'reasonable' layoffs five months after $100M IPO

.Only 5 months after safeguarding a $100 thousand IPO, Boundless Biography is actually already givin...

Halda's $126M will certainly evolve 'hold and kill' tumor medications

.The first stages of oncology R&ampD aren't except intriguing brand new methods, as well as Halda Re...

Lykos 'remorses' certainly not disclosing research study offenses with publisher

.Psychopharmacology has actually pulled three write-ups regarding midstage scientific test data dete...

Analysts dig into Avidity's DMD gain, disclosing nuances in data

.Avidity Biosciences amazed real estate investors along with stage 1/2 information in Duchenne muscu...

Actinogen's cortisol blocker falls short stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a stage 2 research in de...

Bivictrix makes a decision going personal only method to take ADC into medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of many a billion-dollar biobuck l...

TPG tops up funds to $580M for investments across life sciences

.Property manager TPG, which has actually assisted biotechs including Sionna Therapeutics as well as...

Merck stops stage 3 TIGIT trial in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT course has actually suffered another problem. Months after shuttering a phas...

After a challenging year, Exscientia folds up right into Recursion

.After a year defined by pipeline cuts, the departure of its CEO and also discharges, Exscientia wil...

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Therapeutics was impressed enough with Harbour BioMed's bispecific immune system reactor t...